[Lupus erythematosus, modern aspects (author's transl)].
D000863:Antacids / Q000627:therapeutic use; D000974:Antibodies, Antinuclear; D000936:Antigen-Antibody Complex; D001379:Azathioprine / Q000627:therapeutic use; D002699:Chlorambucil / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D003556:Cystitis / Q000139:chemically induced; D004247:DNA; D003920:Diabetes Mellitus / Q000139:chemically induced; D005260:Female; D006562:Herpes Zoster / Q000209:etiology; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000009:adverse effects; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy / Q000276:immunology; D008297:Male; D008593:Menopause; D008727:Methotrexate / Q000627:therapeutic use; D009504:Neutrophils; D011241:Prednisone / Q000627:therapeutic use
D000863:Antacids; D000974:Antibodies, Antinuclear; D000936:Antigen-Antibody Complex; D007166:Immunosuppressive Agents; D002699:Chlorambucil; D003520:Cyclophosphamide; D004247:DNA; D001379:Azathioprine; D011241:Prednisone; D008727:Methotrexate
Le lupus érythémateux disséminé, conceptions actuelles.